{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:06:46Z","timestamp":1790021206171,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["UG1 EY033703"],"award-info":[{"award-number":["UG1 EY033703"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ogla.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:48:30Z","timestamp":1786981710000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-Year Treatment Outcomes of Ahmed Glaucoma Valve Implantation with Adjunctive Intraoperative and Postoperative Mitomycin C"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-6927","authenticated-orcid":false,"given":"Binh","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-531X","authenticated-orcid":false,"given":"Brad","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-1257","authenticated-orcid":false,"given":"Yinxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-1355","authenticated-orcid":false,"given":"Gui-Shuang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius T.","family":"Oatts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5600-7242","authenticated-orcid":false,"given":"Iqbal Ike K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-7971","authenticated-orcid":false,"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2026.08.001_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ophtha.2019.10.002","article-title":"Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of Follow-up","volume":"127","author":"Gedde","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","article-title":"Postoperative complications in the Tube Versus Trabeculectomy (TVT) Study during five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib3","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.ophtha.2011.05.004","article-title":"The Ahmed versus Baerveldt study: one-year treatment outcomes","volume":"118","author":"Christakis","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib4","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2013.04.018","article-title":"The Ahmed versus Baerveldt study: three-year treatment outcomes","volume":"120","author":"Christakis","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ophtha.2016.06.035","article-title":"The Ahmed versus Baerveldt Study","volume":"123","author":"Christakis","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2010.07.016","article-title":"Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year of follow-up","volume":"118","author":"Budenz","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2014.08.043","article-title":"Five-year treatment outcomes in the Ahmed Baerveldt comparison study","volume":"122","author":"Budenz","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jcp.1041040305","article-title":"Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells","volume":"104","author":"Wohlhueter","year":"1980","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ogla.2026.08.001_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2012.10.008","article-title":"New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery","volume":"13","author":"Lockwood","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ogla.2026.08.001_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ophtha.2003.09.037","article-title":"Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma valve implantation: a prospective randomized clinical trial","volume":"111","author":"Costa","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ogla.2026.08.001_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ajo.2008.04.008","article-title":"Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes","volume":"146","author":"Alvarado","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ogla.2020.10.004","article-title":"Subconjunctival injections of Mitomycin C are associated with a lower incidence of hypertensive phase in eyes with Ahmed glaucoma valve","volume":"4","author":"Perez","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2026.08.001_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/1074-5521(95)90120-5","article-title":"Mitomycin C: small, fast and deadly (but very selective)","volume":"2","author":"Tomasz","year":"1995","journal-title":"Chem Biol"},{"key":"10.1016\/j.ogla.2026.08.001_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/archopht.1987.01060030116039","article-title":"Selection of therapeutic agents for intraocular proliferative disease: II. Differing antiproliferative activity of the fluoropyrimidines","volume":"105","author":"Blumenkranz","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/112067210501500105","article-title":"The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation","volume":"15","author":"Kurnaz","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ceo.12811","article-title":"Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation: antifibrotic use after Ahmed valve implantation","volume":"45","author":"Cui","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2020.06.059","article-title":"Comparing treatment outcomes from the tube versus trabeculectomy and primary tube versus trabeculectomy studies","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2022.02.027","article-title":"Risk factors for failure of tube shunt surgery: a pooled data analysis","volume":"240","author":"Bowden","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ophtha.2008.03.031","article-title":"Aqueous shunts in glaucoma: a report by the American Academy of ophthalmology","volume":"115","author":"Minckler","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2014.01.036","article-title":"Three-year treatment outcomes in the Ahmed Baerveldt comparison study","volume":"121","author":"Barton","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.ophtha.2017.05.014","article-title":"Risk factors and long-term outcomes in patients with low intraocular pressure after trabeculectomy","volume":"124","author":"Tseng","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/IJG.0000000000000131","article-title":"Early aqueous suppressant therapy on hypertensive phase following glaucoma drainage device procedure: a randomized prospective trial","volume":"25","author":"Law","year":"2016","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ogla.2026.08.001_bib23","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ophtha.2014.03.014","article-title":"Effect of early treatment with aqueous suppressants on Ahmed glaucoma valve implantation outcomes","volume":"121","author":"Pakravan","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.08.001_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00417-018-4156-9","article-title":"Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature","volume":"257","author":"Ramdas","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2026.08.001_bib25","first-page":"325","article-title":"The AHMED glaucoma valve in neovascular glaucoma (an AOS THESIS)","volume":"107","author":"Netland","year":"2009","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:21:39Z","timestamp":1790018499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419626001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"alternative-id":["S2589419626001341"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2026.08.001","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-Year Treatment Outcomes of Ahmed Glaucoma Valve Implantation with Adjunctive Intraoperative and Postoperative Mitomycin C","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Academy of Ophthalmology, Inc.","name":"copyright","label":"Copyright"}]}}